The detection of certain cardiac issues in a study of healthy volunteers led Aardvark to pause a Phase 3 trial only months before an expected data readout.

Founder and CEO George Kurtz made a compelling argument that we agree with, so why can't the rest of the market get behind him?

Once used by vets to anesthetize elephants, carfentanil is now an extremely dangerous illicit drug often disguised as an ...

If it sounds like Dr. MacBride is describing intelligence, it's because she is. Indeed, some "frustrating" behaviors can ...

Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...

Machine learning models are usually complimented for their intelligence. However, their success mostly hinges on one fundamental aspect: data labeling for machine learning. A model has to get familiar ...

As we start 2026, cloud progress will belong to teams that build confidence through visibility and discipline.

Davos celebrated AI. Paris confronted it. 800 researchers named US absence, a Pentagon power grab, 4,000 jobs erased, and a ...

For National Consumer Protection Week, NAEBA calls for transparency, accurate sales data, and Fair Housing compliance ...

Packaging continues to be a stable and growing industry, with plenty of opportunities for commercial printers to get in on the action. Here’s what 2026 has in store for this segment.

This situation is a great reminder of advice a good friend shared with me years ago: Every difficult moment is a gift. The challenge—for leaders, especially— is developing the discipline to find that ...

Conventional electronic noses rely on arrays of chemical sensors whose electrical responses are often affected by humidity, temperature fluctuations, and long-term drift. While these systems have ...